taxifolin has been researched along with galangin in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (35.00) | 18.2507 |
| 2000's | 1 (5.00) | 29.6817 |
| 2010's | 11 (55.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CJ; Geahlen, RL | 1 |
| Augereau, JM; Billon, M; Gleye, J; Herbert, JM; Lale, A; Leconte, M | 1 |
| Habtemariam, S | 1 |
| Jacobson, KA; Moro, S; Sanders, LH; van Rhee, AM | 1 |
| Carver, JA; Duggan, PJ; Ecroyd, H; Liu, Y; Meyer, AG; Tranberg, CE | 1 |
| Amić, D; Lucić, B | 1 |
| Cai, S; Chu, L; Gao, F; Ji, B; Jia, G; Liu, J; Liu, Y; Wang, A; Wei, Y; Wu, W; Xie, L; Zhang, D; Zhou, F | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Chin, YW; Han, SY; Kong, JY | 1 |
| Akagi, K; Irie, K; Katayama, S; Masuda, Y; Murakami, K; Nakagawa, Y; Sato, M; Takegoshi, K; Uno, M | 1 |
| Bilia, AR; Carta, F; Ceruso, M; Karioti, A; Supuran, CT | 1 |
| Bicknell, KA; Farrimond, JA; Putnam, SE; Swioklo, S; Watson, KA; Williamson, EM | 1 |
| Akagi, K; Hanaki, M; Irie, K; Murakami, K | 1 |
| Fernandes, E; Fernandes, PA; Freitas, M; Oliveira, A; Proença, C; Ramos, MJ; Ribeiro, D; Silva, AMS; Sousa, JLC | 1 |
| Price, KR; Rhodes, MJ; Uda, Y; Williamson, G | 1 |
| Curti, C; Dorta, DJ; Helena, AF; Mingatto, FE; Pigoso, AA; Prado, IM; Rodrigues, T; Santos, AC; Uyemura, SA | 1 |
| Arriero, Mdel M; Monjo, M; Ramis, JM; Satué, M | 1 |
| Gómez-Florit, M; Monjo, M; Ramis, JM | 1 |
| Jacobson, KA; Ji, XD; Melman, N | 1 |
| Calomme, M; Cimanga, K; Cos, P; Hu, JP; Pieters, L; Van Poel, B; Vanden Berghe, D; Vlietinck, AJ; Ying, L | 1 |
1 review(s) available for taxifolin and galangin
| Article | Year |
|---|---|
Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents.
Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Protein-Tyrosine Kinases | 1992 |
19 other study(ies) available for taxifolin and galangin
| Article | Year |
|---|---|
Ability of different flavonoids to inhibit the procoagulant activity of adherent human monocytes.
Topics: Amino Acid Sequence; Blood Coagulation; Cell Adhesion; Endotoxins; Flavonoids; Humans; In Vitro Techniques; Interleukin-1; Molecular Sequence Data; Monocytes | 1996 |
Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-alpha in L-929 tumor cells.
Topics: Animals; Apoptosis; Drug Synergism; Flavonoids; Mice; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1997 |
Flavonoid derivatives as adenosine receptor antagonists: a comparison of the hypothetical receptor binding site based on a comparative molecular field analysis model.
Topics: Binding Sites; Computer Simulation; Flavonoids; Kinetics; Least-Squares Analysis; Models, Molecular; Molecular Conformation; Molecular Structure; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A3; Receptors, Purinergic P1; Regression Analysis; Reproducibility of Results; Static Electricity; Structure-Activity Relationship | 1998 |
Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formation.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Caseins; Flavonoids; Humans; Methylation; Milk; Structure-Activity Relationship | 2010 |
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
Topics: Flavonoids; Free Radical Scavengers; Models, Biological; Quantitative Structure-Activity Relationship; Quantum Theory; Software; Thermodynamics | 2010 |
Comparative study on antioxidant capacity of flavonoids and their inhibitory effects on oleic acid-induced hepatic steatosis in vitro.
Topics: Antioxidants; Cell Line; Fatty Liver; Flavonoids; Humans; In Vitro Techniques; Oleic Acid; Reactive Oxygen Species; Triglycerides | 2011 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Flavonoids as receptor tyrosine kinase FLT3 inhibitors.
Topics: Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Flavonoids; fms-Like Tyrosine Kinase 3; Humans; Luteolin; Protein Kinase Inhibitors | 2013 |
Site-specific inhibitory mechanism for amyloid β42 aggregation by catechol-type flavonoids targeting the Lys residues.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Catechols; Humans; Lysine; Norleucine; Peptide Fragments; Quercetin | 2013 |
New natural product carbonic anhydrase inhibitors incorporating phenol moieties.
Topics: Biological Products; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Humans; Isoenzymes; Kinetics; Phenol; Protein Binding; Quercus; Salvia; Structure-Activity Relationship | 2015 |
Defining Key Structural Determinants for the Pro-osteogenic Activity of Flavonoids.
Topics: Cell Differentiation; Flavonoids; Humans; Mesenchymal Stem Cells; Molecular Structure; Osteogenesis; Signal Transduction; Structure-Activity Relationship | 2015 |
Structural insights into mechanisms for inhibiting amyloid β42 aggregation by non-catechol-type flavonoids.
Topics: Amyloid beta-Peptides; Dose-Response Relationship, Drug; Flavonoids; Molecular Structure; Peptide Fragments; Structure-Activity Relationship | 2016 |
Structural Specificity of Flavonoids in the Inhibition of Human Fructose 1,6-Bisphosphatase.
Topics: Drug Design; Enzyme Inhibitors; Flavonoids; Fructose; Fructose-Bisphosphatase; Humans; Hypoglycemic Agents; Liver; Molecular Structure | 2020 |
Induction of the anticarcinogenic marker enzyme, quinone reductase, in murine hepatoma cells in vitro by flavonoids.
Topics: Animals; Catechin; Chamomile; Enzyme Induction; Enzyme Inhibitors; Flavonoids; Flavonols; Kaempferols; Liver Neoplasms, Experimental; Mice; NAD(P)H Dehydrogenase (Quinone); Oils, Volatile; Plants, Medicinal; Quercetin; Tumor Cells, Cultured | 1997 |
The interaction of flavonoids with mitochondria: effects on energetic processes.
Topics: Adenosine Triphosphate; Animals; Calcium; Catechin; Cell Respiration; Flavonoids; Flavonols; Intracellular Membranes; Luminescent Measurements; Male; Membrane Fluidity; Mitochondria, Liver; Polarography; Quercetin; Rats; Rats, Wistar; Structure-Activity Relationship | 2005 |
Quercitrin and taxifolin stimulate osteoblast differentiation in MC3T3-E1 cells and inhibit osteoclastogenesis in RAW 264.7 cells.
Topics: Animals; Biomarkers; Cell Differentiation; Cell Line; Cell Survival; Flavonoids; Gene Expression; Integrin-Binding Sialoprotein; Macrophages; Mice; Osteoblasts; Osteocalcin; Osteoclasts; Osteogenesis; Quercetin | 2013 |
Identification of quercitrin as a potential therapeutic agent for periodontal applications.
Topics: Adult; Anti-Bacterial Agents; Antioxidants; Cell Culture Techniques; Cell Survival; Cells, Cultured; Collagen; Collagen Type III; Decorin; Female; Fibroblasts; Flavonoids; Gingiva; Humans; Interleukin-6; Male; Matrix Metalloproteinase 1; Middle Aged; Quercetin; Reactive Oxygen Species; Staphylococcus epidermidis; Tissue Inhibitor of Metalloproteinase-1; Wound Healing; Young Adult | 2014 |
Interactions of flavonoids and other phytochemicals with adenosine receptors.
Topics: Animals; Cell Line; CHO Cells; Cricetinae; Flavonoids; Humans; Magnetic Resonance Spectroscopy; Plants; Protein Binding; Radioligand Assay; Rats; Receptors, Purinergic P1 | 1996 |
Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers.
Topics: Enzyme Inhibitors; Flavonoids; Free Radical Scavengers; Structure-Activity Relationship; Xanthine Oxidase | 1998 |